CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in IPSC — Century Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in IPSC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$928,224
+$748,747 QoQ
Shares Held
378,867
+377.1% QoQ
Ownership
0.209%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 98 holders
Holding Since
Sep 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IPSC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. IPSC ranks #231 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in IPSC
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $928,224 | 378,867 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $179,477 | 79,415 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $91,327 | 163,377 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $128,910 | 270,820 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $361,383 | 357,805 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $607,616 | 355,331 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,015,869 | 398,380 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $635,573 | 152,051 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $493,886 | 148,761 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $293,602 | 146,801 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $505,783 | 160,058 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $526,700 | 151,787 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $786,546 | 153,323 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,486,931 | 150,347 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $795,740 | 94,731 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,147,981 | 91,182 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,229,165 | 77,501 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,888,912 | 75,076 | Shares | Sole | 2021-11-16 | |
| No filing history on record for this holder in this stock. | ||||||